A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice
Type 1 diabetes (T1D) is an autoimmune disease caused by the destruction of pancreatic β cells by autoantigen-reactive diabetogenic cells. Antigen-specific therapies using islet autoantigens for restoring immune tolerance have emerged as promising approaches for the treatment of T1D but have been un...
Saved in:
Main Authors: | Hidetoshi Akimoto, Emi Fukuda-Kawaguchi, Omar Duramad, Yasuyuki Ishii, Kazunari Tanabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2019/9430473 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antitumor Responses of Invariant Natural Killer T Cells
by: Jennie B. Altman, et al.
Published: (2015-01-01) -
Invariant Natural Killer T Cells as Key Players in Host Resistance against Paracoccidioides brasiliensis
by: Joes Nogueira-Neto, et al.
Published: (2021-01-01) -
Bioprinting of bespoke islet-specific niches to promote maturation of stem cell-derived islets
by: Myungji Kim, et al.
Published: (2025-02-01) -
Evolution of 𝜷-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation
by: Cyrus Jahansouz, et al.
Published: (2011-01-01) -
Repurposing Lesogaberan to Promote Human Islet Cell Survival and β-Cell Replication
by: Jide Tian, et al.
Published: (2017-01-01)